Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
Clinical trial NCT04924803 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04924803
- Sponsor
- NDRI-USA, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2025-11-25
- Enrollment
- 545
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.